Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -7.62%937.25M | -8.82%2.08B | -8.15%1.52B | -7.17%1.01B | -6.43%470.81M | -13.49%2.28B | -17.94%1.65B | -20.32%1.09B | -22.43%503.16M | -0.51%2.64B |
| Operating income | -7.62%937.25M | -8.82%2.08B | -8.15%1.52B | -7.17%1.01B | -6.43%470.81M | -13.49%2.28B | -17.94%1.65B | -20.32%1.09B | -22.43%503.16M | -0.51%2.64B |
| Cost of sales | 5.87%-209.63M | 15.05%-498.15M | 16.03%-340.36M | 17.81%-222.69M | 12.29%-105.66M | 0.74%-586.43M | 5.47%-405.32M | 5.60%-270.95M | 6.62%-120.46M | -1.11%-590.83M |
| Operating expenses | 5.87%-209.63M | 15.05%-498.15M | 16.03%-340.36M | 17.81%-222.69M | 12.29%-105.66M | 0.74%-586.43M | 5.47%-405.32M | 5.60%-270.95M | 6.62%-120.46M | -1.11%-590.83M |
| Gross profit | -8.12%727.62M | -6.66%1.58B | -5.58%1.18B | -3.67%791.88M | -4.59%365.15M | -17.16%1.7B | -21.32%1.25B | -24.21%822.02M | -26.35%382.7M | -0.97%2.05B |
| Selling expenses | 12.89%-420.47M | 15.98%-908.85M | 15.80%-676.07M | 13.43%-482.68M | 9.25%-252.28M | 17.17%-1.08B | 5.67%-802.9M | 9.76%-557.55M | 20.45%-278.01M | -6.66%-1.31B |
| Administrative expenses | 4.80%-135.66M | 17.00%-315.41M | 2.68%-235.24M | 9.63%-142.5M | 1.74%-80.24M | -10.16%-380M | -0.61%-241.71M | 4.70%-157.68M | -7.66%-81.66M | 2.85%-344.94M |
| Research and development expenses | 21.71%-125.67M | 15.69%-303.84M | 10.80%-230.7M | 5.25%-160.52M | 8.16%-81.3M | 9.97%-360.39M | 8.26%-258.64M | 8.02%-169.41M | 1.52%-88.53M | -18.80%-400.28M |
| Special items of operating profit | -6.25%62.33M | -14.26%137.34M | -4.88%112.49M | -11.76%66.49M | 24.03%35.8M | 78.91%160.18M | 28.70%118.25M | 20.01%75.35M | 25.27%28.86M | 11.77%89.53M |
| Operating profit | 48.81%108.15M | 468.60%191.95M | 139.53%147.43M | 470.88%72.67M | 64.86%-12.88M | -60.44%33.76M | -79.68%61.55M | -92.92%12.73M | -233.51%-36.64M | -63.01%85.34M |
| Financing cost | -251.05%-5.67M | 48.01%-2.84M | -877.97%-10.67M | -125.86%-1.61M | 83.15%-1.2M | -124.87%-5.47M | --1.37M | --6.24M | -87.24%-7.15M | --22M |
| Share of profits of associates | 59.38%2.96M | -40.20%726K | -118.77%-73K | 529.15%1.86M | 163.05%655K | 253.94%1.21M | -21.26%389K | -33.71%295K | 260.87%249K | -70.28%343K |
| Earning before tax | 44.61%105.44M | 543.45%189.84M | 115.91%136.69M | 278.46%72.92M | 69.16%-13.43M | -72.60%29.5M | -81.02%63.31M | -89.99%19.27M | -283.74%-43.54M | -49.82%107.68M |
| Tax | 62.29%-2.6M | -11.76%-14.39M | -6.21%-10.67M | -7.76%-6.89M | 104.78%226K | 28.84%-12.87M | 54.59%-10.05M | 21.21%-6.39M | 55.03%-4.73M | 21.80%-18.09M |
| After-tax profit from continuing operations | 55.76%102.84M | 955.02%175.45M | 136.61%126.02M | 412.94%66.03M | 72.65%-13.2M | -81.44%16.63M | -82.90%53.26M | -93.02%12.87M | -466.37%-48.27M | -53.20%89.59M |
| Earning after tax | 55.76%102.84M | 955.02%175.45M | 136.61%126.02M | 412.94%66.03M | 72.65%-13.2M | -81.44%16.63M | -82.90%53.26M | -93.02%12.87M | -466.37%-48.27M | -53.20%89.59M |
| Minority profit | 8.94%22.54M | 164.48%42M | 167.83%34.73M | 352.58%20.69M | 47.25%-3.11M | -64.88%15.88M | -76.46%12.97M | -89.17%4.57M | -134.84%-5.89M | -20.67%45.22M |
| Profit attributable to shareholders | 77.13%80.3M | 17,693.33%133.45M | 126.56%91.29M | 446.18%45.33M | 76.18%-10.1M | -98.31%750K | -84.28%40.29M | -94.16%8.3M | -1,039.33%-42.38M | -66.99%44.37M |
| Basic earnings per share | 76.68%0.1682 | 17,412.50%0.2802 | 456.73%0.0952 | -98.19%0.0016 | -93.93%0.0171 | -66.43%0.0884 | ||||
| Diluted earnings per share | 75.63%0.1665 | 17,331.25%0.2789 | 457.65%0.0948 | -98.18%0.0016 | -93.93%0.017 | -66.24%0.088 | ||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS and HKAS | IAS | IAS | IAS | IAS and HKAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | PwC accounting firm | -- | -- | -- | KPMG | -- | -- | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.